Transforming Pharma & Biotech Challenges into Success.
At SEQOVA, we don’t just provide solutions— we craft pathways. From regulatory compliance to global market entry, our expertise ensures that every challenge becomes an opportunity for sustainable growth and excellence.
Speak To Us For

Let Us Build Success Together
Partnering with SEQOVA means you’re never navigating challenges alone. We’re here to support your growth every step of the way—empowering your team, streamlining processes, and driving measurable results. If you’re ready to elevate your business and achieve sustainable success, we’re ready to make it happen.
Insights
Why China’s Second- and Third-Tier Biotech Companies Represent Europe’s Most Undervalued In-Licensing Opportunity
Beyond Autologous: Why China’s Allogeneic CAR-T Pipeline Deserves European Attention Now
SEQOVA Biotech Insights | May 2026 The approved CAR-T therapies that reshaped haematological oncology over…
Why Good Assets Don’t Close: The Hidden Weight of Execution
You can usually tell where a deal is going to get difficult.Not at the beginning….
Radiopharmaceuticals 2025–2026: Why Cost, Infrastructure, and Workflow Now Matter More Than Novelty
Radiopharmaceuticals innovation in 2026 have moved decisively beyond their historical niche in nuclear medicine. What…
LAI Licensing in Central Nervous System Disorders: Where Execution Risk Sits in 2026
Interest in long-acting injectables (LAIs) for Central Nervous System (CNS) disorders has returned to business…
Inhalation Drug Licensing in 2026: Why Execution-Ready Assets Are Queitly Winning
For years, inhalation drug licensing has been misunderstood.It wasn’t deprioritized because it failed scientifically. It…
Subscribe
to receive our industry insights

